DRUGS MADE IN AMERICA ACQUISITION II CORP. (DMIIR) Net income
DRUGS MADE IN AMERICA ACQUISITION II CORP. (DMIIR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$4.2MFY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DMIIR financial trends
DMIIR RevenueDMIIR Net marginDMIIR Gross profitDMIIR Gross marginDMIIR Operating incomeDMIIR Operating marginDMIIR Operating cash flowDMIIR Free cash flowDMIIR Capital expendituresDMIIR Return on equityDMIIR Stock buybacksDMIIR Dividends paidDMIIR Total assetsDMIIR Total liabilitiesDMIIR Shareholders’ equityDMIIR overview →